Abstract: Disclosed are injection molds, injected molded articles, and methods for using the same. The injected molds include a mold cavity and an injection molding conduit having a first end, a second end defining an outlet in fluid communication with the mold cavity, a first interior transverse dimension that is perpendicular to a longitudinal axis of the injection molding conduit, a second interior transverse dimension that is perpendicular to the longitudinal axis and to the first interior transverse dimension, and at the second end, the second interior transverse dimension is at least three times larger than the first interior transverse dimension, and the second interior transverse dimension of the injection molding conduit is substantially aligned with a thickness of a portion of the mold cavity that is adjacent to the outlet of the injection molding conduit.

Abstract: Disclosed are injection molds, injected molded articles, and methods for using the same. The injected molds include a mold cavity and an injection molding conduit having a first end, a second end defining an outlet in fluid communication with the mold cavity, a first interior transverse dimension that is perpendicular to a longitudinal axis of the injection molding conduit, a second interior transverse dimension that is perpendicular to the longitudinal axis and to the first interior transverse dimension, and at the second end, the second interior transverse dimension is at least three times larger than the first interior transverse dimension, and the second interior transverse dimension of the injection molding conduit is substantially aligned with a thickness of a portion of the mold cavity that is adjacent to the outlet of the injection molding conduit.

Abstract: A hybrid electric vehicle comprises an engine and an electric propulsion motor, and the vehicle is operable in an HEV mode in which the engine may be switched on automatically during a drive-cycle by a controller and an electric vehicle (EV)-only mode. The vehicle is operable in a plurality of attribute modes in which operating parameters of the vehicle are changed by the controller responsive to the identity of the selected attribute mode, wherein, when in the HEV mode and a first attribute mode is selected, selection of the EV-only mode by the driver results in assumption of the EV-only mode and continued operation in the first attribute mode, and, when in the HEV mode and a second attribute mode is selected, selection of the EV-only mode results in assumption of the EV-only mode and automatic de-selection of the second attribute mode.

Abstract: The invention relates to a hybrid electric vehicle (100) comprising: an engine (121) and at least one electric propulsion motor (123), the vehicle (100) being operable in a HEV mode in which the engine (121) may be switched on automatically during a drive-cycle by control means (140) and an electric vehicle (EV)-only mode in which engine starting is inhibited during a drive-cycle, the vehicle (100) being operable in one of a plurality of attribute modes in which one or more operating parameters of the vehicle (100) are changed by the control means (140) responsive to the identity of the selected attribute mode, wherein when in the HEV mode and a first attribute mode is selected, selection of the EV-only mode by the driver results in assumption of the EV-only mode and continued operation in the first attribute mode, and when in the HEV mode and a second or further attribute mode has been selected, selection of the EV-only mode by the driver results in assumption of the EV-only mode and automatic de-selection b

Abstract: The present invention relates generally to genetic sequences encoding flavonoid pathway metabolising enzymes and more particularly to flavonoid 3?-hydroxylase (hereinafter referred to as “F3?H”) or derivatives thereof and their use in the manipulation of pigmentation in plants and other organisms.

Abstract: The present invention relates to a nucleic acid isolate comprising a sequence of nucleotides encoding, or complementary to a sequence encoding, a dihydrokaempferol (DHK) hydroxylating enzyme or derivative or part thereof. The present invention also relates to transgenic plants carrying and expressing the above mentioned nucleic acid material.

Abstract: The present invention relates to a nucleic acid isolate comprising a sequence of nucleotides encoding, or complementary to a sequence encoding, a dihydrokaempferol (DHK) hydroxylating enzyme or derivative or part thereof. The present invention also relates to transgenie plants carrying and expressing the above mentioned nucleic acid material.